Drug Interactions

propranolol and salbutamol

MajorAvoid this combination where possible.

Mechanism
Propranolol is a non-selective beta-adrenergic antagonist, blocking both beta-1 and beta-2 receptors. Salbutamol is a selective beta-2 agonist that produces bronchodilation by stimulating beta-2 receptors in the airway smooth muscle. Propranolol antagonises the beta-2 receptor action of salbutamol, thereby reducing or abolishing its bronchodilator effect. Additionally, propranolol can directly cause bronchoconstriction by blocking basal beta-2 receptor tone, which is particularly harmful in patients with reactive airways.
What it means clinically
The therapeutic effect of salbutamol is significantly diminished in patients taking propranolol. This can lead to inadequate relief of bronchospasm and worsening of symptoms in asthma or COPD. In susceptible individuals, propranolol may precipitate acute bronchoconstriction, increasing the risk of respiratory distress. The combination may also mask the usual tachycardia induced by salbutamol, indicating a significant degree of beta-2 blockade.
What to do
Avoid concurrent use of propranolol and salbutamol, especially in patients with asthma or COPD. If an alternative antihypertensive agent is not acceptable, consider a cardioselective beta-blocker (e.g., bisoprolol) at the lowest effective dose. If combined, monitor respiratory function closely, including peak flow or spirometry, and assess symptom control. Advise the patient to report any wheezing, breathlessness, or reduced response to their bronchodilator. Consider increasing the dose of salbutamol or adding an alternative bronchodilator, such as an anticholinergic agent, to maintain airway patency.
Evidence
The interaction is well established from pharmacodynamic antagonism and clinical experience. Non-selective beta-blockers are known to oppose beta-2 agonists, and guidelines caution against their use in patients with reversible airway obstruction. The degree of interaction varies among individuals, and some may tolerate the combination without overt symptoms, but the risk of serious respiratory compromise is sufficient to warrant caution.

Practise prescribing around interactions like this one

Oskela marks prescriptions against this interaction database automatically: write a chart for a simulated patient and every clash is caught and explained.

Other interactions involving propranolol or salbutamol

Educational reference for students and clinicians in training. It does not replace professional judgement, local protocols or current prescribing information.